Efficacy and Safety of siRNA JNJ-73763989, Capsid Assembly Modulator-E JNJ-56136379, and Nucleos(t)ide Analogs With Pegylated Interferon Alpha-2a Added in Immune-tolerant Patients With Chronic Hepatitis B Virus Infection: Interim Results From the Phase 2 REEF-IT Study

Conference Reports for NATAP

AASLD
The Liver Meeting
November Fri, Nov 10, 2023 - Mon, Nov 14, 2023


Efficacy and Safety of siRNA JNJ-73763989, Capsid Assembly Modulator-E JNJ-56136379, and Nucleos(t)ide Analogs With Pegylated Interferon Alpha-2a Added in Immune-tolerant Patients With Chronic Hepatitis B Virus Infection: Interim Results From the Phase 2 REEF-IT Study

	AASLD 2023 nov 10-14 https://www.aasld.org/the-liver-meeting